Admission Date: [**2187-12-17**]        Discharge Date: [**2188-2-1**]  Date of Birth:  [**2187-12-17**]        Sex:  F  Service:  NEONATOLOGY   HISTORY:  This infant was considered a 26-week gestational infant admitted to NICU with respiratory distress.
MATERNAL HISTORY:  Mom is a 21-year-old, gravida 2, para [**1-9**], woman with a past OB history notable for a term spontaneous vaginal delivery in [**2185**] (alive and well).
Fever noted to be 99.7 and antibiotic therapy started on [**2187-12-16**], 23 hours prior to delivery.
NEONATAL COURSE:  Infant emerged with moderate tone and heart rate around 60.
She was orally and nasally bulb suctioned, dried and Neopuff mask ventilation administered with a PEEP of 6 and a PIP of 30 cm H2O, with an FIO2 between 50-75%, with normalization of heart rate greater than 100 by 2 minutes of age.
Intubated at 3 minutes of age uneventfully with a 2.5 ET tube.
Respiratory: Infant is in nasal cannula at 25 cc 100%.
RESPIRATORY:  Upon admission to the NICU infant was     intubated, placed on conventional ventilator.
On day of life 2, infant bolused with caffeine     and extubated to CPAP.
Infant transitioned to nasal     cannula on day of life 16 and infant is currently on     nasal cannula of 25 cc in 100%.
Infant is having     occasional episodes of apnea of prematurity and remains     on caffeine citrate therapy.
Enteral feeds began on     dol 7 at 10 mL/kg/D of breast milk or PE20.
Phototherapy was finally discontinued on day of life 15     for a bilirubin of 1.8/0.3, and infant has had a last     bilirubin done on day of life 16 which was 2.0/0.3.
She has received two blood transfusions during her stay     here in the NICU.
Infant     received 48 hours of ampicillin and gentamicin with a     negative blood culture.
Feeds at discharge:  PE 30 at 150 mL/kg/d per gavage.
Medication:  Infant is on vitamin E 5 units PG q. day.
Infant is also receiving ferrous sulfate which comes 25-     1 mg and she is receiving 4 mg/kg/dose.
Iron and vitamin D supplementation:  Iron     supplementation is recommended for preterm and low     birthweight infants until 12 months corrected age.
The     initial one on [**12-20**] revealed an elevated 17-OHP     of 200 (it should be less than 200 for that age).
Immunizations received:  Infant has received the     hepatitis B vaccine on [**1-18**].
Immunizations recommended:     a.    Synagis RSV prophylaxis should be considered from      [**Month (only) **] through [**Month (only) 958**] for infants who meet any of the      following 4 criteria:  1) born at less than or equal to      32 weeks, 2) born between 32 and 35-0/7 weeks with 2 of      the following: daycare during RSV season, a smoker in      the household, neuromuscular disease, airway      abnormalities, or school-aged siblings, 3) chronic lung      disease, or 4) hemodynamically significant congenital      heart disease.
Influenza immunization is recommended annually in      the fall for all infants once they reach 6 months of      age.
